Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by Cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by Cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide
Authors
Keywords
Cannabinoid receptors type 2, Liver fibrosis, TLR4, miR-155, NFκB p65, Vimentin
Journal
CHEMICO-BIOLOGICAL INTERACTIONS
Volume -, Issue -, Pages 109398
Publisher
Elsevier BV
Online
2021-01-24
DOI
10.1016/j.cbi.2021.109398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sitagliptin ameliorates thioacetamide-induced acute liver injury via modulating TLR4/NF-KB signaling pathway in mice
- (2019) Dalia H. El-Kashef et al. LIFE SCIENCES
- Interplay of liver‐heart inflammatory axis and cannabinoid 2 receptor signalling in an experimental model of hepatic cardiomyopathy
- (2019) Csaba Matyas et al. HEPATOLOGY
- Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer
- (2019) Tahereh Hosseinabadi et al. PHYTOTHERAPY RESEARCH
- Cholestasis induced by bile duct ligation promotes changes in the intestinal microbiome in mice
- (2019) Raul Cabrera-Rubio et al. Scientific Reports
- Serum MicroRNA-122 and miR-155 as Biomarkers of Liver Injury and Inflammation in Models of Acute and Chronic Liver Disease
- (2018) Shashi Bala et al. GASTROENTEROLOGY
- Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease
- (2017) Shashi Bala et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cannabis: A Treasure Trove or Pandora's Box?
- (2017) Katalin Solymosi et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
- (2017) Marjolein Soethoudt et al. Nature Communications
- Cannabinoids, inflammation, and fibrosis
- (2016) Robert B. Zurier et al. FASEB JOURNAL
- Silibinin: a potential old drug for cancer therapy
- (2016) Xing-Xing Zhu et al. Expert Review of Clinical Pharmacology
- Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA)
- (2015) Anusha H. Tennakoon et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Hypoxia-induced microRNA-155 promotes fibrosis in proximal tubule cells
- (2015) SHENPING XIE et al. Molecular Medicine Reports
- Changes in Cannabinoid Receptors, Aquaporin 4 and Vimentin Expression after Traumatic Brain Injury in Adolescent Male Mice. Association with Edema and Neurological Deficit
- (2015) Ana Belen Lopez-Rodriguez et al. PLoS One
- LPS promotes epithelial–mesenchymal transition and activation of TLR4/JNK signaling
- (2014) Hangyu Li et al. TUMOR BIOLOGY
- Inhibition of Toll-like receptor 4 suppresses liver injury induced by biliary obstruction and subsequent intraportal lipopolysaccharide injection
- (2013) Shingo Oya et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Monoacylglycerol Lipase Controls Endocannabinoid and Eicosanoid Signaling and Hepatic Injury in Mice
- (2013) Zongxian Cao et al. GASTROENTEROLOGY
- Potential impact of silymarin in combination with chlorogenic acid and/or melatonin in combating cardiomyopathy induced by carbon tetrachloride
- (2013) Nouf M. Al-Rasheed et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- The direct profibrotic and indirect immune antifibrotic balance of blocking the cannabinoid 2 receptor
- (2012) Yosefa Avraham et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- 377 INHIBITION OF THE PRO-FIBROGENIC TH17 IMMUNE RESPONSE BY CANNABINOID RECEPTOR 2 AGONIST DECREASES LIVER FIBROSIS
- (2012) F. Lafdil et al. JOURNAL OF HEPATOLOGY
- Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
- (2011) F. Barutta et al. DIABETES
- Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice
- (2011) Alexandre Louvet et al. HEPATOLOGY
- Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis
- (2011) I-Shu Chen et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Is lipid signaling through cannabinoid 2 receptors part of a protective system?
- (2011) P. Pacher et al. PROGRESS IN LIPID RESEARCH
- Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration
- (2010) Fatima Teixeira-Clerc et al. HEPATOLOGY
- Toll-like Receptor 4 and Hepatic Fibrogenesis
- (2010) Jean-Philippe Pradere et al. SEMINARS IN LIVER DISEASE
- Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression
- (2009) Kai-jie Wu et al. ACTA PHARMACOLOGICA SINICA
- Modulation of extracellular matrix by nutritional hepatotrophic factors in thioacetamide-induced liver cirrhosis in the rat
- (2009) R.R. Guerra et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity
- (2009) Stefan Russmann et al. CURRENT MEDICINAL CHEMISTRY
- Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis
- (2009) Annarosa Floreani et al. JOURNAL OF GASTROENTEROLOGY
- Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice
- (2008) Yosefa Avraham et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started